Canadian sedation dentists received unwelcome news in December when manufacturers announced a backlog in orders for triazolam, a mainstay for those using DOCS Education advanced protocols. With availability of the drug delayed to March 2011 at the earliest, DOCS Education faculty sought to provide solutions and keep patients protected. “We have conducted many seminars in Canada and feel a responsibility to helping dentists and patients through this problematic period,” explains president Dr. Michael Silverman, DMD. Led by Dr. Silverman and DOCS Education general counsel John Bitting, the webinar was originally broadcast on January 6. The 90-minute program covered one of five advanced protocols taught as part of the company’s Sedation Solution course. An additional 30 minutes was spent answering questions. The session covered use of midezolam and hydroxyine and was only open to dentists who had already taken Sedation Solutions or Oral Sedation Dentistry within the previous two years. Learn how you can view the webinar here.

The information contained in this, or any case study post in Incisor, should never be considered a proper replacement for necessary training and/or education regarding adult oral conscious sedation. Regulations regarding sedation vary by state. This is an educational and informational piece. DOCS Education accepts no liability whatsoever for any damages resulting from any direct or indirect recipient's use of or failure to use any of the information contained herein. DOCS Education would be happy to answer any questions or concerns mailed to us at 3250 Airport Way S, Suite 701 | Seattle, WA 98134. Please print a copy of this posting and include it with your question or request.
DOCS Membership
Upcoming Events

More Articles

Consent for Emergency Treatment during COVID-19
March Madness: Responding to the COVID-19 Outbreak with Game Winning Strategies
Give Your Dental Marketing A Minute a Week
Navigating the River of Doubt
Reputation Management Tips for Dentists